Clinical trial
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal…
NCT00165698 · Eisai Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00165698 |
|---|---|
| Title | Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women |
| Official title | Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women |
| Lead sponsor | Eisai Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postmenopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | menatetranone, alfacalcidol |
| Enrollment | 240 |
| Start date | May 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Jul 22, 2014 |
| Countries | China |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: